SIZE XSSIZE SMSIZE MDSIZE LG

Drug Updates

The following information helps you to find FDA Alerts and Pharmacist’s Applications to Practice quickly and easily. In cooperation with the Food and Drug Administration (FDA), and as a service to our members, HOPA periodically distributes information about newly approved therapies for cancer patients from FDA’s Office of Oncology Drug Products Director, Dr. Richard Pazdur to inform oncologists and professionals in oncology-related fields in a timely manner. Links to product labels will take you to relevant clinical information on the indication, contraindications, dosing, and safety. In sending this information, HOPA does not endorse any product or therapy and does not take any position on the safety or efficacy of the product or therapy described.

Along with HOPA’s Publications Committee, members also review new drug updates and provide analysis and research on the application of these new drugs or indications. Pharmacist’s Applications to Practice, or PAP, are listed after drugs that include the additional analysis.

  • Yes
  • Encorafenib (BRAFTOVI, Array BioPharma Inc.) in combination with Cetuximab
    2020-04-08    
    Package Insert
  • Ripretinib (QINLOCK, Deciphera Pharmaceuticals, LLC.)
    2020-05-15    
    Package Insert
  • Abatacept (ORENCIA, Bristol-Myers Squibb Company)
    2021-12-15    
    Package Insert
  • Abemaciclib (VERZENIO, Eli Lilly & Company)
    2021-10-12    
    Package Insert
  • Alpelisib (VIJOICE, Novartis Pharmaceuticals)
    2022-04-06    
    Package Insert
  • Amivantamab-vmjw (RYBREVANT, Janssen Biotech, Inc.) with PAP
    2021-05-21    
    Package Insert
  • Asciminib (SCEMBLIX, Novartis AG)
    2021-10-29    
    Package Insert
  • Asparaginase erwinia chrysanthemi (RYLAZE, Jazz Pharmaceuticals, Inc.) with PAP
    2021-06-30    
    Package Insert
  • Atezolizumab (TECENTRIQ, Genentech, Inc.) – all entries with PAPs
    2021-10-15    
    Package Insert
  • Avapritinib (AYVAKIT, Blueprint Medicines) – all entries with PAPs
    2021-06-16    
    Package Insert
  • Axicabtagene ciloleucel (YESCARTA, Kite Pharma, Inc.)
    2022-04-01    
    Package Insert
  • Azacitidine (ONUREG, Celgene Corporation)
    2020-09-01    
    Package Insert
  • Azacitidine (VIDAZA, Celgene Corp.)
    2022-05-20    
    Package Insert
  • Belantamab mafodotin-blmf (Blenrep, GlaxoSmithKline) with PAP
    2020-08-05    
    Package Insert
  • Belumosudil (REZUROCK, Kadmon Pharmaceuticals, LLC)
    2021-07-16    
    Package Insert
  • Belzutifan (WELIREG, Merck) with PAP
    2021-08-13    
    Package Insert
  • Brexucabtagene autoleucel (TECARTUS, Kite Pharma, Inc.) – all entries with PAPs
    2021-10-01    
    Package Insert
  • Cabozantinib (CABOMETYX, Exelixis, Inc.)
    2021-09-17    
    Package Insert
  • Capmatinib (TABRECTA, Novartis) – all entries with PAPs
    2022-08-10    
    Package Insert
  • Carfilzomib (KYPROLIS, Onyx Pharmaceuticals, Inc.)
    2021-11-30    
    Package Insert
  • Cemiplimab-rwlc (LIBTAYO, Regeneron Pharmaceuticals Inc.) – all entries with PAPs
    2021-02-22    
    Package Insert
  • Cetuximab (ERBITUX, ImClone LLC)
    2021-04-06    
    Package Insert
  • Ciltacabtagene autoleucel (CARVYKTI, Janssen Biotech, Inc.)
    2022-02-28    
    Package Insert
  • Crizotinib (XALKORI, Pfizer Inc.), Juno Therapeutics, Inc.) – all entries
    2022-07-14    
    Package Insert
  • Dabrafenib (TAFINLAR, Novartis)
    2022-06-22    
    Package Insert
  • Daratumumab and Hyaluronidase-fihj (DARZALEX FASPRO, Janssen Biotech, Inc.) – all entries with PAPs
    2021-11-30    
    Package Insert
  • Darolutamide (NUBEQA, Bayer HealthCare Pharmaceuticals Inc.)
    2022-08-05    
    Package Insert
  • Decitabine and Cedazuridine (INQOVI, Astex Pharmaceuticals, Inc.) with PAP
    2020-07-07    
    Package Insert
  • Dostarlimab-gxly (JEMPERLI, GlaxoSmithKine LLC) – all entries
    2021-08-17    
    Package Insert
  • Durvalumab (Imfinzi™, AstraZeneca UK Limited)—all entries with PAPS
    2022-09-02    
    Package Insert
  • Enfortumab vedotin-ejfv (PADCEV, Astellas Pharma US, Inc.)
    2021-07-09    
    Package Insert
  • Fam-trastuzumab deruxtecan-nxki (ENHERTU, Daiichi Sankyo, Inc.) – all entries with PAPs
    2022-08-11    
    Package Insert
  • Futibatinib (LYTGOBI, Taiho Oncology, Inc.)
    2022-09-30    
    Package Insert
  • Ibrutinib (IMBRUVICA, Pharmacyclics LLC)
    2022-08-24    
    Package Insert
  • Idecabtagene Vicleucel (ABECMA, Bristol Myers Squibb) with PAP
    2021-03-26    
    Package Insert
  • Infigratinib (TRUSELTIQ, QED Therapeutics, Inc.) with PAP
    2021-05-28    
    Package Insert
  • Isatuximab-irfc (SARCLISA, Sanofi-Aventis U.S. LLC) – all entries with PAPs
    2021-03-31    
    Package Insert
  • Ivosidenib (TIBSOVO, Servier Pharmaceuticals LLC)
    2022-05-25    
    Package Insert
  • Lisocabtagene maraleucel (BREYANZI, Juno Therapeutics, Inc.) – all entries with PAPs
    2022-06-24    
    Package Insert
  • Loncastuximab tesirine-lpyl (ZYNLONTA, ADC Therapeutics SA) with PAP
    2021-04-23    
    Package Insert
  • Lorlatinib (LORBRENA, Pfizer Inc.)
    2021-03-03    
    Package Insert
  • Lurbinectedin (ZEPZELCA, Pharma Mar S.A.)
    2020-06-15    
    Package Insert
  • Lutetium Lu 177 vipivotide tetraxetan (PLUVICTO, Advanced Accelerator Applications USA, Inc., a Novartis company)
    2022-03-23    
    Package Insert
  • Margetuximab-cmkb (MARGENZA, MacroGenics) with PAP
    2020-12-16    
    Package Insert
  • Melphalan flufenamide (PEPAXTO, Oncopeptides AB)
    2021-02-26    
    Package Insert
  • Mitomycin (JELMYTO, UroGen Pharma)
    2020-04-15    
    Package Insert
  • Mobocertinib (EXKIVITY, Takeda Pharmaceuticals, Inc.) with PAP
    2021-09-15    
    Package Insert
  • Naxitamab (DANYELZA, Y-mAbs Therapeutics, Inc.) with PAP
    2020-11-25    
    Package Insert
  • Neratinib (Nerlynx, Puma Biotechnology, Inc.) with PAP
    2020-02-25    
    Package Insert
  • Niraparib (ZEJULA™, Tesaro, Inc.), all entries with PAP
    2020-04-29    
    Package Insert
  • Nivolumab (OPDIVO, Bristol-Myers Squibb Co.) – all entries with PAPs
    2022-05-27    
    Package Insert
  • Nivolumab (OPDIVO, Bristol-Myers Squibb Co.) plus ipilimumab (YERVOY, Bristol-Myers Squibb Co.) – all entries
    2020-10-02    
    Package Insert
  • Nivolumab and relatlimab-rmbw (OPDUALAG, Bristol-Myers Squibb Company)
    2022-03-18    
    Package Insert
  • Olaparib (LYNPARZA, AstraZeneca Pharmaceuticals) - all entries with PAPs
    2022-03-11    
    Package Insert
  • Osimertinib (TAGRISSO, AstraZeneca Pharmaceuticals)—all entries and PAPs
    2020-12-18    
    Package Insert
  • Pembrolizumab (KEYTRUDA, Merk & Co.) – all entries with PAPs
    2022-03-21    
    Package Insert
  • Pemigatinib (PEMAZYRE, Incyte Corporation) – all entries with PAPs
    2022-08-26    
    Package Insert
  • Phesgo—a combination of pertuzumab, trastuzumab and hyaluronidase–zzxf
    2020-06-29    
    Package Insert
  • Pralsetinib (GAVRETO, Blueprint Medicines Corporation) – all entries with PAPs
    2020-12-01    
    Package Insert
  • Reblozyl (luspatercept–aamt) all entries
    2020-04-03    
    Package Insert
  • Relugolix (ORGOVYX, Myovant Sciences, Inc.) with PAP
    2020-12-18    
    Package Insert
  • Rituximab (RITUXAN, Genentech, Inc.)
    2021-12-02    
    Package Insert
  • Ruxolitinib (JAKAFI, Incyte Corp.)
    2021-09-22    
    Package Insert
  • Sacituzumab govitecan (TRODELVY, Immunomedics Inc.) – all entries with PAPs
    2021-04-13    
    Package Insert
  • Selinexor (XPOVIO, Karyopharm Therapeutics, Inc.) – all entries with PAPs
    2020-12-18    
    Package Insert
  • Selpercatinib (RETEVMO, Eli Lilly and Company) – all entries with PAPs
    2022-09-21    
    Package Insert
  • Selumetinib (KOSELUGO, AstraZeneca)
    2020-04-10    
    Package Insert
  • Sirolimus protein-bound particles (FYRARRO, Aadi Bioscience, Inc.)
    2021-11-22    
    Package Insert
  • Sotorasib (LUMAKRAS, Amgen, Inc.) with PAP
    2021-05-28    
    Package Insert
  • Tafasitamab-cxix (MONJUVI, MorphoSys US Inc.) with PAP
    2020-07-31    
    Package Insert
  • Tazemetostat (Tazverik, Epizyme, Inc.) all entries with PAP
    2020-06-18    
    Package Insert
  • Tebentafusp-tebn (KIMMTRAK, Immunocore Limited)
    2022-01-25    
    Package Insert
  • Teclistamab-cqyv (TECVAYLI, Janssen Biotech, Inc.)
    2022-10-25    
    Package Insert
  • Tepotinib (TEPMETKO, EMD Serono Inc.) with PAP
    2021-02-03    
    Package Insert
  • Tisagenlecleucel (KYMRIAH, Novartis Pharmaceuticals Corporation)
    2022-05-27    
    Package Insert
  • Tisotumab vedotin-tftv (TIVDAK, Seagen, Inc.) with PAP
    2021-09-20    
    Package Insert
  • Tivozanib (FOTIVDA, AVEO Pharmaceuticals, Inc.)
    2021-03-10    
    Package Insert
  • Tremelimumab (IMJUDO, AstraZeneca Pharmaceuticals)
    2022-10-21    
    Package Insert
  • Tucatanib (TUKYSA, Seattle Genetics, Inc.)
    2020-04-17    
    Package Insert
  • Umbralisib (UKONIQ, TG Therapeutics) with PAP
    2021-02-05    
    Package Insert
  • Venetoclax (VENCLEXTA, AbbVie, Inc. & Genentech USA, Inc.) - all entries and PAPs
    2020-10-16    
    Package Insert
  • Zanubrutinib (BRUKINSA, BeiGene) – all entries
    2021-09-14    
    Package Insert
  • Yes
xs
sm
md
lg